Hydromer Expands European Medical Coating Access Through Avem Partnership
TL;DR
Hydromer's partnership with Avem gives medical device developers a competitive edge by providing faster access to advanced coating technologies that enhance device performance and reduce time to market.
The partnership combines Hydromer's coating platforms and R&D support with Avem's regional expertise to systematically help manufacturers scale from prototype to full production while navigating regulatory requirements.
This collaboration makes advanced medical coatings more accessible worldwide, potentially improving patient outcomes through better performing medical devices and accelerating healthcare innovation.
Hydromer's decades of coating expertise now connects directly with European medtech innovators through Avem, bringing specialized surface technologies to new medical device applications.
Found this article helpful?
Share it with your network and spread the knowledge!

Hydromer, Inc. has entered into a commercial partnership with Avem Market Solutions to strengthen its reach and technical support capabilities for medical device developers throughout Europe and the United Kingdom. This collaboration creates a more accessible pathway for European device manufacturers requiring advanced surface solutions by leveraging Avem's expertise in connecting Medtech OEMs and CDMOs with specialized suppliers.
The partnership provides European and UK medtech companies with direct access to Hydromer's hydrophilic, lubricious, antimicrobial, and thrombo-resistant coating platforms. Avem will serve as Hydromer's strategic representative in the region, offering custom formulation and R&D support for early development, scalable coating equipment and tailored system design, and localized commercial guidance from a team immersed in the EU and UK medtech ecosystems. This unified approach aims to help developers reduce time to market, enhance device performance, and streamline the transition from prototype to full-scale manufacturing.
This partnership addresses the increasing pressure European and UK medtech companies face to innovate quickly while meeting strict regulatory expectations. By combining Hydromer's deep scientific expertise with Avem's regional commercial insight, the collaboration makes advanced coating solutions easier to access, understand, and implement. Device manufacturers gain earlier visibility into validated coating options, hands-on support for feasibility studies and scale-up, a reliable resource for navigating technical and operational challenges, and a direct channel to explore coating technologies proven in global markets.
Hydromer's coatings have been integrated into devices used in interventional, surgical, and diagnostic procedures worldwide for decades. The company maintains ISO 9001:2015 certification and facilities compliant with Good Manufacturing Practice, ISO 13485, and ISO 9001 standards. Through this partnership, European manufacturers can access Hydromer's proprietary coating formulations, custom coating services, research and development capabilities, analytical testing, technology transfer, and dedicated machinery building, installation, and support services available at https://www.hydromer.com.
The collaboration is designed to eliminate barriers and empower innovators at every stage of product development, providing a comprehensive solution for medical device companies seeking to enhance their products' performance and safety profiles while accelerating their path to market in the competitive European healthcare landscape.
Curated from NewMediaWire

